Loading...

Longevity Health Holdings Inc.

XAGE•NASDAQ
Healthcare
Biotechnology
$3.88
$-0.18(-4.43%)

Longevity Health Holdings Inc. (XAGE) Company Profile & Overview

Explore Longevity Health Holdings Inc.’s business operations, leadership, sector classification, and key company facts including IPO date, industry, and contact details.

Longevity Health Holdings Inc. (XAGE) Company Profile & Overview

Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.

SectorHealthcare
IndustryBiotechnology
CEORajiv Sarman Shukla

Contact Information

https://www.carmellcosmetics.com
412 894 8248
2403 Sidney Street, Pittsburgh, PA, 15203

Company Facts

15 Employees
IPO DateSep 23, 2021
CountryUS
Actively Trading

Frequently Asked Questions

;